Exenatide comes in two dosage forms, one is 5 μg per injection, containing a 30-day supply, and costs around$1500. The other is 10μg per injection, also containing a 30-day supply, and costs around$1,800. Exenatide is an enteroglucagon, which is a glucose concentration-dependent insulinotropic agent, in short, it can prompt insulin secretion according to the concentration of glucose in the body, therefore, hypoglycemia is not easy to occur with Exenatide. At the same time, Exenatide has the effect of slowing down the emptying of gastric contents, improving the function of pancreatic islet cells and protecting cardiovascular. Exenatide can reduce blood glucose and weight at the same time, the clinical use of exenatide, in the selection of patients will choose overweight or obese patients, insulin amount is relatively large or oral multiple oral medications and poor glycemic control of type 2 diabetes mellitus patients. Because exenatide is a glucose-dependent insulinotropic agent, it is not prone to hypoglycemia, so middle-aged and elderly people can also choose this drug. On top of the choice of treatment regimen, metformin combined with exenatide is usually used for treatment. If metformin combined with exenatide treatment is not ideal for lowering blood sugar, sulfonylureas or insulin can also be added. If the blood sugar is not too high diabetic patients, you can also take exenatide monotherapy, clinical can often see the initial diagnosis of blood sugar is not particularly high in obese patients, the use of exenatide treatment for six months or so, can appear to blood sugar return to normal, and then stop the drug situation. At present, in some areas, exenatide has not been included in the scope of medical insurance, compared with other hypoglycemic drugs is more expensive, so, in the choice of exenatide at the same time to listen to the doctor’s advice, but also with their own actual situation.